Precedex ®
An Innovation in IV Sedation
Effective and different. That’s Precedex, the first and only alpha2 agonist indicated for sedation:
- In nonintubated patients prior to and/or during surgical and other procedures.1
- In initially intubated and mechanically ventilated patients during treatment in an intensive care setting.1
This site provides step-by-step instructions on how to start using Precedex and what to expect with this IV sedative.
The fastest growing IV sedative for the last 2 yrs in a row
Indications and Safety Information
Precedex is indicated for sedation in nonintubated patients prior to and during surgical and other procedures and in intubated and mechanically ventilated patients during treatment in an intensive care setting.
Precedex should be administered by continuous infusion not to exceed 24 hours.
Caution should be exercised when administering Precedex to patients with advanced heart block and/or severe ventricular dysfunction.
Clinically significant episodes of bradycardia, sinus arrest and hypotension have been associated with Precedex infusion and may necessitate medical intervention.
Please see a more complete description of these and other Warnings and Precautions in the full prescribing information.
© 2010 HOSPIRA, INC. LAKE FOREST, ILLINOIS, U.S.A.
This Website and its information is intended for use by United States residents only. Countries outside the United States may have regulatory requirements, data requirements or medical practices that differ from the United States and, therefore, this information may be inappropriate for use outside the United States. Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, CONTACT HOSPIRA.